Gender-affirming HIV care as a tool to end the HIV epidemic.
Gender-affirming HIV care as a tool to end the HIV epidemic.
复制标题
DOI:
10.1016/s2352-3018(23)00087-5
复制
发表时间:
2023-06
期刊:
影响因子:
16.1
通讯作者:
Restar, Arjee
中科院分区:
文献类型:
--
作者:
Wirtz, Andrea L.;Restar, Arjee
Transgender (trans) women have borne a disproportionate burden of HIV infection globally and have contributed substantially to advancing HIV prevention and care to end the epidemic. 1 Yet, few studies have sufficient sample sizes and measures appropriate for trans women or involved trans investigators, which are needed to generate population-specific inferences and inform HIV strategies for trans women. Dr. Cloete and colleagues report HIV prevalence and HIV care indicators from one of the first biobehavioral surveys exclusively for trans women in South Africa. 2 This research adds to a growing body of global evidence that demonstrates that rigorous research exclusively for trans women can and should be done. 3–6Dr. Cloete and colleagues employed respondent-driven sampling (RDS) to reach and recruit over 880 sexually active trans women in three metropolitan areas of South Africa. 2 RDS methodology has a dual benefit of leveraging social networks and community trust to sample populations for whom no sampling frame exists and providing statistical methods that approximate population-based prevalence estimates. While RDS’benefits are welldocumented, it has not always been applied successfully in reaching trans women. Rather, the successful engagement of trans women in this research is likely attributed to the coupling of rigorous research methods with a community-engaged implementation strategy, ie, the joint involvement of trans scholars, leaders, and trans-led organizations in all study phases. 7 Building on the scientific and community expertise of these partners, community-engaged research enhances scientific research questions are salient to communities; ensures that the